Search results
Merck & Co., Inc. (NYSE:MRK) is largely controlled by institutional shareholders who own 77% of the...
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Institutions' substantial holdings in Merck implies that they have significant...
Here's What Merck & Co., Inc.'s (NYSE:MRK) Shareholder Ownership Structure Looks Like
Simply Wall St. via Yahoo Finance· 2 years agoEvery investor in Merck & Co., Inc. (NYSE:MRK) should be aware of the most powerful shareholder...
Merck & Co., Inc. (NYSE:MRK) is a favorite amongst institutional investors who own 78%
Simply Wall St. via Yahoo Finance· 8 months agoKey Insights Institutions' substantial holdings in Merck implies that they have significant...
Merck & Co. (MRK) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoImage source: The Motley Fool. Merck & Co. (NYSE: MRK) Q2 2022 Earnings Call Jul 28, 2022, 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers...
Merck & Co., Inc.'s (NYSE:MRK) high institutional ownership speaks for itself as stock continues to...
Simply Wall St. via Yahoo Finance· 1 year agoIf you want to know who really controls Merck & Co., Inc. (NYSE:MRK), then you'll have to look at...
Merck & Co., Inc. (NYSE:MRK) Shares Could Be 50% Below Their Intrinsic Value Estimate
Simply Wall St. via Yahoo Finance· 4 months agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Merck fair value estimate is US$215 Merck...
Q4 2023 Merck & Co Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 months agoParticipants Caroline Litchfield; Executive VP & CFO; Merck & Co., Inc. Dean Y. Li; Executive VP & President of Merck Research Laboratories; Merck & Co., Inc. Peter Dannenbaum; VP of IR; Merck ...
Cancer-Focused Imago BioSciences Shares Soar After Merck Deal
Benzinga via Yahoo Finance· 1 year agoMerck & Co Inc (NYSE: MRK) has agreed to acquire Imago BioSciences Inc (NASDAQ: IMGO) for $36.00 per...
Merck Shows Takeover Interest In Seagen: WSJ
Benzinga via Yahoo Finance· 2 years agoMerck & Co Inc (NYSE: MRK) is reportedly mulling buying cancer-focused biotech Seagen Inc (NASDAQ: SGEN), Wall Street Journal reported citing people...
Merck allies with Daiichi Sankyo in major bet on antibody cancer drugs
BioPharma Dive via Yahoo Finance· 7 months agoMerck & Co. is making a major investment in the future of its cancer drug business, agreeing to one...
